Doxil/Caelyx BE Study
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Ovarian Cancer|AIDS-related Kaposi Sarcoma|Multiple Myeloma|Metastatic Breast Cancer
Interventions: DRUG: DOXIL/CAELYX
Sponsor: Baxter Healthcare Corporation